NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...
Experiments suggests H9N2 has adapted to human cells, but cases of person-to-person transmission haven’t been reported yet ...
NHS staff started testing people who turned up in scores of hospital casualty departments and had to tell thousands that they ...
China's GDIIST research institute has announced the development and soon release of the BIE-1, an AI supercomputer inspired ...
When he inserted a breathing tube into Monet’s windpipe, the patient vomited, covering Dr Musoke’s face and clothes in vomit. Some entered Dr Musoke’s mouth ...
Scientists found a virus-like living entity in human bodies named "obelisks" - small loops of RNA, each a thousand genetic ...
NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
Experiments suggests H9N2 has adapted to human cells but cases of person-to-person transmission haven’t been reported yet.
4d
Investornewsbreaks Nanoviricides (NYSE American: NNVC) To Present At PODD 2025 Conference In Boston
To Present At PODD 2025 Conference In Boston. NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing broad-spectrum antiviral drugs designed to prevent viral escape, will ...
Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback